Evidence map›Paper›PMID 31836585›Full record

ArticleCold Spring Harbor molecular case studies2019

Genome sequencing for early-onset or atypical dementia: high diagnostic yield and frequent observation of multiple contributory alleles.

J Nicholas Cochran, Emily C McKinley, Meagan Cochran, Michelle D Amaral, Bryan A Moyers, Brittany N Lasseigne, David E Gray, James M J Lawlor, Jeremy W Prokop, Ethan G Geier and 10 more

Open access · diamondAbstract read
In one paragraph

Article in Cold Spring Harbor molecular case studies, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Integrative genomic and functional analyses reveal NINL as a modulator of tau aggregation.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Article
  4. IsmedRxiv : the preprint server for health sciences · 2026
    Article
  5. Article
  6. Article
  7. Deciding on genetic testing for familial dementia: Perspectives of patients and families.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson's disease models.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Contributions of rare and common variation to early-onset and atypical dementia risk.medRxiv : the preprint server for health sciences · 2023
    Article
  13. Article
  14. Review
  15. Heterozygous and Homozygous Variants inInternational journal of molecular sciences · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

J Nicholas CochranHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.ORCID 0000-0002-6027-5052
Emily C McKinleyAlzheimer's Disease Center, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.ORCID 0000-0002-7265-480X
Meagan CochranHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.
Michelle D AmaralHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.
Bryan A MoyersHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.
Brittany N LasseigneHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.ORCID 0000-0002-1642-8904
David E GrayHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.
James M J LawlorHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.ORCID 0000-0003-1735-1766
Jeremy W ProkopHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.ORCID 0000-0002-1818-9695
Ethan G GeierDepartment of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, California 94158, USA.
James M HoltHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.ORCID 0000-0001-6411-9236
Michelle L ThompsonHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.
J Scott NewberryHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.
Jennifer S YokoyamaDepartment of Neurology, Memory and Aging Center, University of California San Francisco, San Francisco, California 94158, USA.
Elizabeth A WortheyHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.
David S GeldmacherAlzheimer's Disease Center, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
Marissa Natelson LoveAlzheimer's Disease Center, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.ORCID 0000-0002-7537-3587
Gregory M CooperHudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.
Richard M Myers *HudsonAlpha Institute for Biotechnology, Huntsville, Alabama 35806, USA.ORCID 0000-0001-9701-676X
Erik D Roberson *Alzheimer's Disease Center, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
HudsonAlpha Institute for Biotechnology · USUniversity of Alabama at Birmingham · USUniversity of California, San Francisco · US

Funding

Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Gil Dan Rabinovici · 2019 to 2026
$36.9M
South-seq: DNA sequencing for newborn nurseries in the SouthU01HG007301 · NHGRI · HUDSON-ALPHA INSTITUTE FOR BIOTECHNOLOGY · PI BARSH, GREGORY STEFAN, COOPER, GREGORY MICHAEL · 2017 to 2021
$11.9M
NHGRI NIH HHS U01 HG007301NIA NIH HHS P30 AG062422
6 · The paper itself

Abstract

We assessed the results of genome sequencing for early-onset dementia. Participants were selected from a memory disorders clinic. Genome sequencing was performed along with

Indexed as

AgedAllelesAlzheimer DiseaseApolipoprotein E4Base SequenceC9orf72 ProteinChromosome MappingDementiaFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyHumansMaleMiddle AgedApolipoprotein E4C9orf72 ProteinC9orf72 protein, humanAlzheimer diseasefrontotemporal dementia

Identifiers

PMID31836585
PMCPMC6913143
OpenAlexW2995055308

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.